NCT01634308CompletedPhase 3
Efficacy and Safety of Bongros-BMP Compared to Bio-oss for Regeneration of Alveolar Bone Tissue After Maxillary Sinus Floor Augmentation
Daewoong Pharmaceutical Co. LTD.1 site in 1 countryStarted: June 2010Last updated:
Conditions
Interventions
Drugs
Trial Snapshot
- Phase
- Phase 3
- Status
- Completed
- Sponsor
- Locations
- 1
Study Overview
Brief Summary
The purpose of this Clinical study was to evaluate the Efficacy and Safety of bongros-BMP compared to Bio-oss for Regeneration of alveolar bone tissue after Maxillary sinus floor augmentation.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Arms & Interventions
Novosis(bongros/BMP-2)
Experimental
Intervention: Novosis(bongros/BMP-2) (Drug)
Bio-oss
Active Comparator
Intervention: Bio-oss (Drug)
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 1
Study to Evaluate the Safety, Pharmacokinetics and Target Engagement of BMS-986142 in Healthy SubjectsHealthy AdultNCT02257151Bristol-Myers Squibb118
Terminated
Phase 2
An Investigational Study to Evaluate the Safety and Effectiveness of BMS-986165 With Background Treatment in Participants With Lupus NephritisLupus NephritisNCT03943147Bristol-Myers Squibb16
Active, not recruiting
Phase 3
A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate CancerMetastatic Castration-resistant Prostate CancerNCT06764485Celgene960
Completed
Phase 4
PEG-rhG-CSF in Patients With Breast Cancer Receiving ChemotherapyBreast CancerNCT02805153CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.215
Completed
Phase 1
Study of BMS-562086 in the Treatment of Outpatients With Major Depressive DisorderMajor Depressive DisorderNCT00135421Bristol-Myers Squibb271